Chronic Idiopathic Urticaria
Conditions
Interventions
treatment group: bleeding therapy with cupping and Ebastine tablets
cupping group:cupping and Ebastine tablets
Ebastine group:Ebastine tablets
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. urticaria diagnosed by criteria from EAACI/GA2LEN/EDF/WAO/Urticaria Guidline; 2. score of UAS7 no less than 28; 3. aged between 18~70 years male and female; 4. vollenteers who sign up the informed consent and capable of following physicians' advice.
Exclusion criteria
Exclusion criteria: 1. patient has been taking antihistamine drugs within 3 days, or corticosteroid, non-steroidal anti-inflammatory drugs or immunosuppressive drugs within 1 month; 2. course of urticaria more than 2 years; 3. autoimmune urticaria; 4. severe autoimmune diseases such SLE; 5. allergic to Ebastine; 6. pregnant or lactating women; 7. thrombocytopenia and coagulation dysfunction; 8. abnomal blood routine, liver function or kidney function examination; 9. patients with severe systemic symptoms accompanied by shock, with obvious surgical injuries, specific causes of infection, or high fever, dizziness, headache, and vomiting during visit; 10. combined with severe primary diseases such as cardiovascular diseases, diabetes, bone metabolism abnormalities, liver or kidney diseases, acute stage of asthma or hematopoietic diseases; Others: patients with mental illness; ulcer, infection or scar on the treatment site.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urticaria Activity Score, UAS; | — |
Countries
China
Contacts
Public ContactMa Biru
Guangdong Hospital of Chinese Medicine
Outcome results
None listed